CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 354 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01526629
NCT01526629N/ACompleted

Identification of Implantable Cardioverter Defibrillator Patients With Remote Follow up That Requires an Onsite Visit

Medtronic Cardiac Rhythm and Heart Failure·observational·Posted Feb 6, 2012·Updated Jul 2, 2025

In Brief

An observational study for Tachyarrhythmia. Completed, enrolled 354 participants across 1 site.

Detailed Summary

With the expansion of Sudden Cardiac Death (SCD) primary prevention indications, the number of Implantable Cardioverter Defibrillators (ICD) implants has increased significantly in the recent years. This has resulted in an increase of the number of follow-up (FU) to be performed and a growing workload for centers. Remote FU system such as the Medtronic Carelink system allows to check remotely the proper functioning of self evaluating devices and give informations of some clinical events. The objective of this study is to define which patients with a remote follow-up need additional onsite visit and to assess to which extent remote FU can be an alternative to onsite visit.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTachyarrhythmia
CountriesFrance
CollaboratorsMedtronic

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 6, 2012
Enrollment StartMay 1, 2011
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 14.4 years ago